ASPDH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.930500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.289400E-01
Normal-vs-Stage2
3.226400E-02
Normal-vs-Stage3
4.736400E-01
Normal-vs-Stage4
4.836600E-01
Stage1-vs-Stage2
3.358200E-01
Stage1-vs-Stage3
3.362000E-01
Stage1-vs-Stage4
3.323600E-01
Stage2-vs-Stage3
9.875200E-01
Stage2-vs-Stage4
4.965600E-01
Stage3-vs-Stage4
7.073200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.001800E-02
Normal-vs-AfricanAmerican
6.227000E-01
Normal-vs-Asian
6.618600E-01
Caucasian-vs-AfricanAmerican
3.642400E-02
Caucasian-vs-Asian
4.209800E-02
AfricanAmerican-vs-Asian
8.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.085500E-02
Normal-vs-Female
1.653180E-01
Male-vs-Female
6.327000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.212800E-01
Normal-vs-Age(41-60Yrs)
4.086400E-02
Normal-vs-Age(61-80Yrs)
9.153900E-02
Normal-vs-Age(81-100Yrs)
1.127030E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.353200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.302800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.246200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.699400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.312050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.174400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.667000E-01
Normal-vs-Daily Drinker
1.284790E-01
Normal-vs-Weekly Drinker
5.807200E-01
Normal-vs-Occasional Drinker
2.140200E-01
Normal-vs-Social Drinker
2.958200E-01
Non Drinker-vs-Daily Drinker
1.721420E-01
Non Drinker-vs-Weekly Drinker
6.319000E-01
Non Drinker-vs-Occasional Drinker
2.687000E-01
Non Drinker-vs-Social Drinker
3.374400E-01
Daily Drinker-vs-Weekly Drinker
1.529370E-01
Daily Drinker-vs-Occasional Drinker
9.402400E-01
Daily Drinker-vs-Social Drinker
8.483000E-01
Weekly Drinker-vs-Occasional Drinker
2.450600E-01
Weekly Drinker-vs-Social Drinker
3.198200E-01
Occasional Drinker-vs-Social Drinker
8.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.577700E-02
Normal-vs-Grade 2
4.17809999997409E-06
Normal-vs-Grade 3
3.878800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.380200E-02
Grade 1-vs-Grade 3
8.393800E-02
Grade 1-vs-Grade 4
6.577700E-02
Grade 2-vs-Grade 3
9.994400E-01
Grade 2-vs-Grade 4
4.17809999997409E-06
Grade 3-vs-Grade 4
3.878800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.896160E-01
Normal-vs-NonDiabetic
6.001600E-02
Diabetic-vs-NonDiabetic
2.153800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.279400E-01
Normal-vs-NoPancreatitis
5.615700E-02
Pancreatitis-vs-NoPancreatitis
6.102400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.632400E-02
Normal-vs-N1
3.661600E-02
N0-vs-N1
1.558990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.547700E-02
Normal-vs-TP53-NonMutant
3.223800E-02
TP53-Mutant-vs-TP53-NonMutant
4.154300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
